First National Bank of Omaha’s Genomic Health, Inc. GHDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-30,105
| Closed | -$1.03M | – | 395 |
|
|
2017
Q4 | $1.03M | Buy |
30,105
+4,425
| +17% | +$151K | 0.06% | 282 |
|
|
2017
Q3 | $824K | Buy |
25,680
+350
| +1% | +$11.2K | 0.05% | 291 |
|
|
2017
Q2 | $824K | Sell |
25,330
-410
| -2% | -$13.3K | 0.05% | 290 |
|
|
2017
Q1 | $811K | Buy |
25,740
+4,553
| +21% | +$143K | 0.05% | 299 |
|
|
2016
Q4 | $623K | Buy |
21,187
+122
| +0.6% | +$3.59K | 0.04% | 308 |
|
|
2016
Q3 | $609K | Buy |
21,065
+2,340
| +12% | +$67.7K | 0.04% | 251 |
|
|
2016
Q2 | $485K | Buy |
18,725
+25
| +0.1% | +$648 | 0.04% | 252 |
|
|
2016
Q1 | $463K | Sell |
18,700
-1,085
| -5% | -$26.9K | 0.03% | 268 |
|
|
2015
Q4 | $696 | Sell |
19,785
-4,565
| -19% | -$161 | 0.05% | 224 |
|
|
2015
Q3 | $515 | Buy |
24,350
+7,625
| +46% | +$161 | 0.04% | 255 |
|
|
2015
Q2 | $453 | Hold |
16,725
| – | – | 0.03% | 296 |
|
|
2015
Q1 | $453 | Buy |
16,725
+805
| +5% | +$22 | 0.03% | 296 |
|
|
2014
Q4 | $509K | Buy |
15,920
+3,245
| +26% | +$104K | 0.04% | 290 |
|
|
2014
Q3 | $359K | Hold |
12,675
| – | – | 0.03% | 321 |
|
|
2014
Q2 | $347K | Buy |
+12,675
| New | +$347K | 0.02% | 338 |
|